Search alternatives:
point decrease » point increase (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
point decrease » point increase (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), awd decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
-
2461
-
2462
-
2463
-
2464
MVEC:AoAF interactions are dependent on signaling through ALK5.
Published 2020“…<p>(<b>A</b>) Representative images of microvascular tubules in 3:3 MVEC:AoAF co-cultures in degradable 7.5wt% hydrogels with 3 mM RGD after 14 days of culture with 1 μM A83-01 (ALK5 inhibitor) or DMSO (control). …”
-
2465
JMJD5 forms a complex with CRY1–FBXL3 and leads to CRY1 degradation.
Published 2018“…<p>(A) JMJD5 interacts with CRY1. Co-IP experiments show the binding profile of (B) FBXL3 and (C) JMJD5 with CRY1 WT and the indicated CRY1 mutants. …”
-
2466
-
2467
-
2468
-
2469
-
2470
-
2471
-
2472
Conformational changes measured by fluorescence correlation spectrometry (FCS).
Published 2017“…Decreasing the SDS concentration to 0.02% resulted in aggregation of all recombinant proteins to a different extent, being highest with wt-rPrP and lowest with H95G-rPrP. …”
-
2473
-
2474
-
2475
-
2476
-
2477
-
2478
-
2479
-
2480
PowerPoint Slides for: Plasma Exchange as an Adjunctive Therapy for Crescentic IgA Nephropathy
Published 2016“…It also significantly decreased plasma IgA-IgG complex levels (pre-PE: 85.3 ± 25.9% vs. post-PE: 38.4 ± 12.4%, p < 0.001) and plasma and urinary active complement product levels, including C3a, C5a and soluble C5b-9. …”